Oma Fertility vs Noom
Side-by-side comparison of AI visibility scores, market position, and capabilities
Oma Fertility operates affordable mini IVF clinics using a lower-stimulation protocol that reduces medication costs and side effects, making IVF accessible to more patients.
About
Oma Fertility is a fertility clinic company founded in 2019 that operates a network of fertility clinics using minimal stimulation IVF (mini IVF) as a primary treatment approach, offering IVF at significantly lower cost than conventional high-stimulation protocols. Mini IVF uses fewer and lower doses of fertility medications, reducing medication costs from $3,000-5,000 to a fraction of that amount while also decreasing the risk of ovarian hyperstimulation syndrome. Oma pairs this lower-cost clinical model with efficient clinic operations, transparent pricing, and subscription plans that make ongoing IVF cycles economically sustainable for patients who might otherwise not afford conventional IVF. The company has raised $40M and operates multiple clinic locations primarily in the Midwest and Southeast United States, targeting the large population of fertility patients who are priced out of conventional IVF at $20,000+ per cycle. Oma Fertility has positioned itself in the value segment of the fertility clinic market, complementing premium networks like Kindbody by serving cost-conscious patients who prioritize affordability and accessibility over premium clinic amenities.
Noom is a digital weight health program combining psychology-based behavioral coaching, food logging, and human coaching to help members build sustainable healthy habits.
About
Noom is a digital health company founded in 2008 that has grown into one of the most widely used weight management platforms, serving millions of members through its psychology-driven approach to behavior change. The platform combines daily lessons on cognitive behavioral techniques, food logging with a traffic-light color-coding system, personal coaching from trained health coaches, and group support to help members change their relationship with food and exercise. Noom raised over $540M and reached a $3.7B valuation, establishing it as a leading consumer digital health company. The company has expanded beyond weight loss into a broader weight health platform addressing both weight management and weight-related conditions including type 2 diabetes management with its Noom Med offering that includes GLP-1 medication prescribing. As GLP-1 medications like Ozempic and Wegovy have transformed the weight loss market, Noom has positioned its behavioral coaching as essential to sustainable results alongside medication. The platform serves both direct-to-consumer subscribers and employer health plans that offer Noom as a weight management benefit for their workforces.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.